ALLR
ALLR
NASDAQ · Biotechnology

Allarity Therapeutics Inc

$0.97
-0.06 (-5.98%)
Financial Highlights (FY 2026)
Revenue
361.4K
Net Income
-12,660,162
Gross Margin
—
Profit Margin
-3,509.7%
Rev Growth
—
D/E Ratio
0.14
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — 55.4% 55.4% 55.4%
Operating Margin -3,939.1% -22.3% -24.2% -22.7%
Profit Margin -3,509.7% -29.6% -25.2% -30.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 361.4K 2.19M 1.96M 2.40M
Gross Profit — 1.21M 1.09M 1.33M
Operating Income -14,237,377 -487,059 -473,882 -545,220
Net Income -12,660,162 -647,190 -493,473 -738,397
Gross Margin — 55.4% 55.4% 55.4%
Operating Margin -3,939.1% -22.3% -24.2% -22.7%
Profit Margin -3,509.7% -29.6% -25.2% -30.8%
Rev Growth — +18.0% +10.8% +10.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.08M 1.72M 1.54M 1.78M
Total Equity 7.59M 6.23M 6.69M 6.01M
D/E Ratio 0.14 0.28 0.23 0.30
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -14,208,037 -712,204 -583,546 -705,797
Free Cash Flow — -781,686 -525,232 -735,953